{
  "id": 162758,
  "name": "REGENERON PHARMACEUTICALS, INC.",
  "slug": "regeneron-pharmaceuticals-inc",
  "state": "NY",
  "description": "Pharmaceutical development and research company",
  "totalSpending": 1750000,
  "filings": 18,
  "yearlySpending": [
    {
      "year": 2018,
      "income": 450000
    },
    {
      "year": 2019,
      "income": 460000
    },
    {
      "year": 2020,
      "income": 170000
    },
    {
      "year": 2021,
      "income": 500000
    },
    {
      "year": 2022,
      "income": 170000
    }
  ],
  "firms": [
    "VENN STRATEGIES"
  ],
  "lobbyists": [
    "STEPHANIE SILVERMAN",
    "NATASCHA CUMBERLIDGE",
    "TIM CAREY",
    "ELIZABETH LEE",
    "MICHAEL SPIRA",
    "AUSTIN ROBERTS",
    "LYNDSAY CARRENO",
    "KELLY FERGUSON",
    "MELISSA FRANCIS (FORMERLY BONICELLI)",
    "OLIVIA NEISTAT",
    "EMILIA DISANTO",
    "ELISE TOLLEFSON",
    "PETER FAWLEY",
    "GRANT COUCH"
  ],
  "issues": [
    "HCR",
    "TAX"
  ],
  "sampleDescriptions": [
    "General issues related to the bio-pharmaceutical sector, innovation, and health care manufacturing.",
    "Tax issues affecting publicly traded biotechnology companies.",
    "General issues related to the bio-pharmaceutical sector, innovation, patient access, and health care manufacturing.",
    "Tax issues affecting publicly traded biotechnology companies",
    "General issues related to the bio-pharmaceutical sector, innovation, patient access, and health care manufacturing.\n\nAlso, in response to in response to the coronavirus pandemic, issues related to the strategic national stockpile and the COVID rescue packages.",
    "General issues related to the bio-pharmaceutical sector, innovation, patient access, health care manufacturing, and pandemic preparedness/response.",
    "Measures related to U.S. international and corporate tax policy."
  ],
  "years": [
    2018,
    2019,
    2020,
    2021,
    2022
  ],
  "growthRate": -62,
  "trajectory": "declining",
  "yearsActive": 5,
  "avgAnnualSpending": 350000,
  "peakYear": 2021,
  "lobbyistCount": 14,
  "firmCount": 1,
  "issueCount": 2,
  "industry": "healthcare"
}